Latest Administration News

Page 85 of 135
Optiscan Imaging Ltd has entered a five-year exclusive collaboration with Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein drug AK-FLOUR®, supporting US clinical trials and FDA regulatory submissions for Optiscan’s InVue® surgical device.
Ada Torres
Ada Torres
23 June 2025
ENRG Elements Limited has confirmed the materiality of recent director resignations and appointments, clarifying timing and compliance with ASX disclosure rules.
Maxwell Dee
Maxwell Dee
20 June 2025
Mosaic Brands’ administrators have adjourned the second creditors’ meeting after no restructuring proposal was submitted, prolonging uncertainty over the retail group’s future.
Logan Eniac
Logan Eniac
20 June 2025
Neurizon Therapeutics reveals that its lead drug candidate NUZ-001 and its metabolite effectively penetrate the blood-brain barrier and reverse pathological protein aggregation linked to ALS, marking a critical step forward in neurodegenerative disease treatment.
Ada Torres
Ada Torres
20 June 2025
EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.
Ada Torres
Ada Torres
19 June 2025
Lumos Diagnostics has enrolled 500 patients in its FebriDx CLIA waiver clinical study, unlocking a significant milestone payment from BARDA and moving closer to FDA approval that could open a US$1 billion market.
Ada Torres
Ada Torres
18 June 2025
Makilala Mining has appointed leading consultants to refine and optimise the MCB Copper-Gold Project’s mine plan and infrastructure design, aiming to enhance operational efficiency and environmental outcomes.
Maxwell Dee
Maxwell Dee
18 June 2025
Wrkr Ltd has completed a pivotal pilot of its employer services platform with Rest and MUFG Retirement Services, setting the stage for streamlined Payday Super implementation ahead of the July 2026 deadline.
Claire Turing
Claire Turing
17 June 2025
CSL has secured FDA approval for ANDEMBRY®, a pioneering treatment for hereditary angioedema, enabling an immediate US launch with promising clinical results. This milestone marks a significant advance in managing a rare but debilitating condition.
Ada Torres
Ada Torres
17 June 2025
Lotus Resources has begun cold commissioning at its Kayelekera uranium project, targeting a Q3 2025 production restart while adopting an owner-operator mining model to reduce costs and enhance control.
Maxwell Dee
Maxwell Dee
17 June 2025
TALi Digital has acquired the You Can Do It! Education program, integrating social-emotional learning into its digital health platform, supported by a $1.5 million equity raise to fund growth and technology reintegration.
Sophie Babbage
Sophie Babbage
16 June 2025
Astron Corporation is set to redomicile from Hong Kong to Australia, establishing a new Australian parent company and simplifying shareholder engagement. This move aims to align governance with local standards and boost investor confidence.
Maxwell Dee
Maxwell Dee
16 June 2025